Testing atomoxetine and DAW2022 for obstructive sleep apnea severity
Treatments studied
Part of Brain & nervous system, Lungs & breathing clinical trials.
This study tests whether atomoxetine and DAW2022 can improve how severe obstructive sleep apnea is. It may help by changing breathing patterns during sleep, measured through physiology tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have obstructive sleep apnea that is moderate-to-severe (at least 15 breathing events per hour).
- You are able and medically stable enough to do breathing/physiology measurements during sleep study visits.
- You are not taking medicines that can significantly change breathing (like opioids or some anti-seizure/respiratory drugs).
- You are not taking antidepressants called SNRIs or SSRIs.
- You do not have other sleep breathing problems (like central sleep apnea) or other sleep disorders like narcolepsy or major restless-leg movement issues.
- You have no known allergy to the study drugs, no prior major reaction like hives or swelling.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the medication trazodone can help people with moderate to severe obstructive sleep apnea (OSA). If you have OSA and are not taking certain medications or have other sleep disorders, you may be able to join.
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
This trial tests whether combining electrical stimulation (via an Inspire device you already have or will get) with two medications can better treat obstructive sleep apnea. You'll help researchers understand if this combination works better than the device alone.
This early study tests a medicine that is meant to improve how your brain and breathing muscles work during sleep for obstructive sleep apnea (OSA). If you qualify, you would be monitored during sleep to see whether the treatment changes breathing events and oxygen levels.
This study tests a new proactive therapy for people recently diagnosed with moderate or severe sleep apnea. It aims to see how well patients stick with the treatment outside of a sleep lab.
This study tests two different ways to help people breathe better during sleep. If you were recently diagnosed with obstructive sleep apnea (OSA), this trial may help you find which device works best for your condition.
Hear when a new Obstructive Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.